ScholarIQanswers from OpenAlex
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both
PaperCitations, authors & open-access status
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both have?
ScholarIQcitation count
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both has 6 citations in the OpenAlex counts ScholarIQ stores.
When was Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both published?
ScholarIQyear
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both has 2025 year in the ScholarIQ index.
What is the open-access status of Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both?
ScholarIQoa status
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both has hybrid oa status in the ScholarIQ index.
What is the DOI of Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both?
ScholarIQdoi
The DOI for Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both is on the source record.
What is the PMID of Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both?
ScholarIQpmid
The PMID for Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both is on the source record.
What is the OpenAlex record for Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both?
ScholarIQopenalex
The OpenAlex for Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both is on the source record.